Publications
5808 Results
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr 3531); American Society of Clinical Oncology Annual Meeting (May 29-June 2,2015, Chicago, IL), poster session;
- Year
- 2015
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/N0147
Relationship between metformin use and recurrence and survival in patients (pts) with resected stage III colon cancer (CC) Receiving Adjuvant Chemotherapy: Results from NCCTG N0147 (Alliance).
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr 6504); American Society of Clinical Oncology Annual Meeting (May 29-June 2,2015, Chicago, IL), oral;
- Year
- 2015
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80405
Cost of chemotherapy for metastatic colorectal cancer with either bevacizumab or cetuximab: economic analysis of CALGB/SWOG 80405
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr 4005); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), oral;
- Year
- 2015
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80701
Randomized phase II study of everolimus alone (E) versus everolimus plus bevacizumab (E+B) in patients with locally advanced or metastatic pancreatic neuroendocrine tumors, CALGB 80701
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr TPS7583); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), poster session;
- Year
- 2015
- Research Committee(s)
- Lung
- Study Number(s)
- CTSU/E4512
ALCHEMIST: a clinical trial platform to bring genomic discovery and molecularly targeted therapies to early-stage lung cancer
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr 533); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), poster session;
- Year
- 2015
- Research Committee(s)
- Breast
Recurrence score and clinicopathologic characteristics of TAILORx participants by race and ethnicity
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr 1007); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), oral;
- Year
- 2015
- Research Committee(s)
- Breast
- Study Number(s)
- CTSU/C40603
Impact of neoadjuvant therapy on breast conservation rates in triple- negative and HER2-positive breast cancer: combined results of CALGB 40603 and 40601 (Alliance)
- Journal / Conference
- Clinical Cancer Research, Apr 1;21(7):1514-1524
- Year
- 2015
- Research Committee(s)
- Lung
- PMID
- PMID25680375
- PMC
- PMC4654466
- Study Number(s)
- S1400
Lung Master Protocol (Lung-MAP) biomarker-driven protocol for accelerating development of therapies for squamous cell lung cancer: SWOG S1400
- Journal / Conference
- Haematologica Sep;100(9):1214-1221
- Year
- 2015
- Research Committee(s)
- Myeloma
- PMID
- PMID26022710
- PMC
- PMC4800692
- Study Number(s)
- S0120
Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120)
- Journal / Conference
- Lancet Oncology Jun;16(6):645-655
- Year
- 2015
- Research Committee(s)
- Early Therapeutics and Rare Cancers and Head and Neck
- PMID
- PMID25957714
- PMC
- n/a
- Study Number(s)
- SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis
- Journal / Conference
- International Journal of Radiation Oncology, Biology, Physics Nov 93(3):Supplement S136, Abst. 310; ASTRO Annual Meeting (October 18-21, 2015, San Antonio, TX), oral presentation;
- Year
- 2015
- Research Committee(s)
- Breast